FindTrial
Sign In

Study of Quercetin Treatment on Gene Expression in Bovine Oocytes.

Comparative study on Activation of Nrf2, PARP1 and ACTB gene on Bovine Oocytes with and without treated with Quercetin. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103617
Enrollment
72
Registered
2026-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

Saveetha Institute of Medical and Technical Sciences SIMATS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 1year and 3yrs & above age group Bovine Oocytes. 2. Nrf2, PARP1 and ACTB gene

Exclusion criteria

Exclusion criteria: 1. 5yrs & above and Degradated Oocytes. 2. Other Antioxidant genes.

Design outcomes

Primary

MeasureTime frame
The elevated levels of Nrf2, PARP1 and ACTB gene in treated sample compare to control Timepoint: Gene expression to be identified after 22hrs of incubated Oocytes with and without Treated with Quercetin—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Nidhi Sharma S

Saveetha institute of Medical and Technical Sciences (SIMATS)

nidhisharma.smc@saveetha.com9445560392

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026